|
EP3366282A1
|
|
Solid oral pharmaceutical compositions of ivabradine
|
|
EP3360543A1
|
|
Pharmaceutical compositions of vilazodone hydrochloride
|
|
EP3360542A1
|
|
Tablet forms of vilazodone hydrochloride
|
|
EP3360541A1
|
|
Pharmaceutical bilayer tablet composition of atorvastatin calcium and ezetimibe
|
|
EP3354262A1
|
|
Enteric coated pharmaceutical compositions of dexlansoprazole
|
|
WO2018122384A1
|
|
Oral pharmaceutical compositions comprising tadalafil and dapoxetine
|
|
EP3342404A1
|
|
Pharmaceutical compositions of diclofenac and eletriptan
|
|
EP3342401A1
|
|
Bilayer tablet formulations of dabigatran etexilate
|
|
WO2018115300A1
|
|
Capsule compositions comprising donepezil and memantine
|
|
EP3551172A1
|
|
Pharmaceutical compositions of dabigatran
|
|
EP3551171A1
|
|
Solid oral pharmaceutical compositions of ticagrelor
|
|
WO2018104387A1
|
|
Multilayered tablet compositions of dabigatran
|
|
EP3326653A1
|
|
Delayed release dosage forms comprising dimethyl fumarate
|
|
EP3318279A1
|
|
Solid oral pharmaceutical compositions of lurasidone hydrochloride
|
|
EP3263096A1
|
|
Pharmaceutical capsule composition of rivaroxaban
|
|
EP3246020A1
|
|
New oral pharmaceutical formulations of dabigatran
|
|
WO2017182641A1
|
|
Bilayer tablet formulations of montelukast and rupatadine
|
|
WO2017182644A1
|
|
Tablet formulations of montelukast sodium and rupatadine fumarate
|
|
WO2017134200A1
|
|
A novel pharmaceutical composition of vorapaxar and metoprolol
|
|
EP3187176A1
|
|
Paliperidone mini tablets
|
